secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELUTIA INC. (ELUT)
CIK:        0001708527
Form:       8-K
Filed at:   2023-11-20T23:59:59+00:00
Accession:  0001558370-23-019243
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elutia recasts 2022 financials to reflect sale of Orthobiologics business as discontinued operations
--------------------------------------------------------------------------------

- Completed sale of Orthobiologics business to Berkeley Biologics LLC on November 8, 2023 for an undisclosed amount.
- Asset Purchase Agreement with Berkeley dated September 17, 2023 triggered discontinued operations classification.
- Historical results of Orthobiologics business reclassified as discontinued operations in recast 2022 Form 10-K.
- Company now operates three segments: Device Protection, Women's Health, and Cardiovascular after sale.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708527/000155837023019243/0001558370-23-019243-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708527/000155837023019243/elut-20231120x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-019243

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer